Kidney cancer mortality statistics

Deaths

Deaths from kidney cancer, 2016, UK.

Percentage of all deaths

Percentage kidney cancer contributes to total cancer deaths, 2016, UK

Age

Peak mortality rate for kidney cancer, 2014-2016, UK

 

Trend over time

Change in kidney cancer mortality rates since the early 1970s, UK

Kidney cancer is the 13th most common cause of cancer death in the UK, accounting for 3% of all cancer deaths (2016).[1-3]

In males in the UK, kidney cancer is the 10th most common cause of cancer death (3% of all male cancer deaths). In females in the UK it is the 14th most common cause of cancer death (2% of all female cancer deaths).

62% of kidney cancer deaths in the UK are in males, and 38% are in females.

Kidney cancer mortality rates (European age-standardised (AS) rates Open a glossary item ) for persons are significantly higher than the UK average in Scotland, and similar to the UK average in all other UK constituent countries.

Kidney Cancer (C64-C66,C68), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2016

  England Scotland Wales Northern Ireland UK
Male Deaths 2374 314 135 58 2881
Crude Rate 8.7 12.0 8.8 6.3 8.9
AS Rate 10.5 14.3 9.5 9.0 10.7
AS Rate - 95% LCL 10.1 12.7 7.9 6.7 10.4
AS Rate - 95% UCL 11.0 15.8 11.1 11.4 11.1
Female Deaths 1413 192 84 49 1738
Crude Rate 5.1 6.9 5.3 5.2 5.2
AS Rate 5.0 6.7 4.8 5.7 5.2
AS Rate - 95% LCL 4.7 5.7 3.8 4.1 4.9
AS Rate - 95% UCL 5.3 7.6 5.8 7.2 5.4
Persons Deaths 3787 506 219 107 4619
Crude Rate 6.9 9.4 7.0 5.7 7.0
AS Rate 7.4 9.9 6.9 7.0 7.6
AS Rate - 95% LCL 7.2 9.0 6.0 5.6 7.4
AS Rate - 95% UCL 7.7 10.7 7.9 8.3 7.8

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate  Open a glossary item
 

For kidney cancer, there are mortality differences between countries despite there being no such differences in incidence.

References

  1. Data were provided by the Office for National Statistics on request, October 2017. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, December 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2016, ICD-10 C64-C66, C68.

Last reviewed:

Kidney cancer mortality is strongly related to age, with the highest mortality rates being in older people. In the UK in 2014-2016, on average each year more than half (52%) of deaths were in people aged 75 and over.[1-3] This largely reflects higher incidence and lower survival for kidney cancer in older people.

Age-specific mortality rates rise steadily from around age 40-44 and more steeply from around age 65-69. The highest rates are in the 90+ age group for males and females.

Mortality rates are significantly higher in males than females in a number of (mainly older) age groups. The gap is widest at age 45 to 49, when the age-specific mortality rate is 2.8 times higher in males than females.

Kidney Cancer (C64-C66,C68), Average Number of Deaths per Year and Age-Specific Mortality Rates per 100,000 Population, UK, 2014-2016

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, October 2017. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp
  3. Data were provided by the Northern Ireland Cancer Registry on request, December 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2014-2016, ICD-10 C64-C66, C68.

Last reviewed:

Kidney cancer European age-standardised (AS) Open a glossary item mortality rates for males and females combined increased by 74% in the UK between 1971-1973 and 2014-2016.[1-3] The increase was of a similar size in males and females.

For males, kidney cancer AS mortality rates in the UK increased by 73% between 1971-1973 and 2014-2016. For females, kidney cancer AS mortality rates in the UK increased by 67% between 1971-1973 and 2014-2016.

Over the last decade in the UK (between 2004-2006 and 2014-2016), kidney cancer AS mortality rates for males and females combined increased by 5%. In males AS mortality rates remained stable, and in females rates remained stable.

Kidney Cancer (C64-C66, C68), European Age-Standardised Mortality Rates per 100,000 Population, UK, 1971-2016

For most cancer types, mortality trends largely reflect incidence and survival trends. For example, rising mortality may reflect rising incidence and stable survival, while falling mortality may reflect rising incidence and rising survival.

Kidney cancer mortality rates have varied between age groups in males and females combined in the UK since the early 1970s.[1-3] Rates in 0-24s have decreased by 64%, in 25-49s have remained stable, in 50-59s have remained stable, in 60-69s have increased by 30%, in 70-79s have increased by 83%, and in 80+s have increased by 254%.

Kidney Cancer (C64-C66, C68), European Age-Standardised Mortality Rates per 100,000 Population, By Age, UK, 1971-2016

References

  1. Data were provided by the Office for National Statistics on request, October 2017. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, December 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1971-2016, ICD-10 C64-C66, C68.

Last reviewed:

Kidney cancer mortality rates are projected to fall by 15% in the UK between 2014 and 2035, to 8 deaths per 100,000 people by 2035.[1] This includes a smaller decrease for males than for females.

For males, kidney cancer European age-standardised (AS) Open a glossary item mortality rates in the UK are projected to fall by 11% between 2014 and 2035, to 11 deaths per 100,000 by 2035.[1] For females, rates are projected to fall by 27% between 2014 and 2035, to 4 death per 100,000 by 2035.[1]

Kidney cancer (C64-C66, C68), Observed and Projected Age-Standardised Mortality Rates, by Sex, UK, 1979-2035

 

It is projected that 5,739 deaths from kidney cancer (3,958 in males, 1,781 in females) will occur in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C64-C66, C68

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is evidence for an association between kidney cancer mortality and deprivation for both males and females in England.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are 28% higher for males living in the most deprived areas compared with the least deprived, and 44% higher for females.[1]

Kidney Cancer (C64-C66, C68), European Age-Standardised Mortality Rates by Deprivation Quintile, England, 2007-2011

The estimated deprivation gradient in kidney cancer mortality between people living in the most and least deprived areas in England has not changed in the period 2002-2011.[1] It has been estimated that there would have been around 340 fewer cancer deaths each year in England during 2007-2011 if all people experienced the same mortality rates as the least deprived.[1]

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for: UK, 2007-2011, ICD-10 C64-C66, C68

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Kidney cancer (C44-C66) is the 10th most common cause of cancer death in Europe, with around 49,000 deaths from kidney cancer in 2012 (3% of the total). In Europe (2012), the highest World age-standardised mortality rates for kidney cancer are in Lithuania for men and the Czech Republic for women; the lowest rates are in Cyprus for men and Luxembourg for women. UK Kidney cancer mortality rates are estimated to be the 20th lowest in males in Europe, and 12th highest in females.[1] These data are broadly in line with Europe-specific data available elsewhere.[2]

Kidney cancer (C44-C66) is the 16th most common cause of cancer death worldwide, with more than 143,000 deaths from kidney cancer in 2012 (2% of the total). Kidney cancer mortality rates are highest in Central and Eastern Europe and lowest in Micronesia and Polynesia, but this partly reflects varying data quality worldwide.[1]

References

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed December 2013.
  2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al.Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer (2013) 49, 1374-1403.

About this data

Data is for: Europe and worldwide, 2012, ICD-10 C44-C66

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 1.9 out of 5 based on 16 votes
Thank you!
We've recently made some changes to the site, tell us what you think